Welcome to LookChem.com Sign In|Join Free

CAS

  • or

105183-60-6

Post Buying Request

105183-60-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

105183-60-6 Usage

General Description

Boc-L-HoMoser-Obzl is a chemical compound with the structure Boc-L-homoserine-O-benzyl. It is a derivative of homoserine, an amino acid that is a precursor to methionine and threonine in the biosynthesis of proteins. The "Boc" group in the compound refers to the tert-butyloxycarbonyl protecting group, which is commonly used in peptide synthesis to protect the amine group of amino acids. The "Obzl" group signifies the presence of a benzyl ester, which is also a common protective group in organic synthesis. Boc-L-HoMoser-Obzl is likely used in the synthesis of peptide and protein derivatives for research and pharmaceutical purposes.

Check Digit Verification of cas no

The CAS Registry Mumber 105183-60-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,1,8 and 3 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 105183-60:
(8*1)+(7*0)+(6*5)+(5*1)+(4*8)+(3*3)+(2*6)+(1*0)=96
96 % 10 = 6
So 105183-60-6 is a valid CAS Registry Number.

105183-60-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-tert-butoxycarbonylamino-4-hydroxybutyric acid benzyl ester

1.2 Other means of identification

Product number -
Other names BOC-HOSER-OBZL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:105183-60-6 SDS

105183-60-6Relevant articles and documents

Synthesis of orthogonally protected L-homocysteine and L-2-amino-4-phophonobutanoic acid from L-homoserine

Nair,Lee,Hangauer

, p. 810 - 814 (1995)

Convenient syntheses of N-tert-butoxycarbonyl-S-p-methoxybenzyl-L-homocysteine benzyl ester and benzyl L-4-dimethylphosphono-2-N-phthalimidobutanoate from commercially available L-homoserine are described along with their incorporation into dipeptides.

Light Harvesting for Rapid and Selective Reactions: Click Chemistry with Strain-Loadable Alkenes

Singh, Kamaljeet,Fennell, Christopher J.,Coutsias, Evangelos A.,Latifi, Reza,Hartson, Steve,Weaver, Jimmie D.

, p. 124 - 137 (2018)

Intramolecular strain is a powerful driving force for rapid and selective chemical reactions, and it is the cornerstone of strain-induced bioconjugation. However, the use of molecules with built-in strain is often complicated as a result of instability or selectivity issues. Here, we show that such strain, and subsequent cycloadditions, can be mediated by visible light via the harvesting of photochemical energy. Through theoretical investigations and molecular engineering of strain-loadable cycloalkenes, we demonstrate the rapid chemoselective cycloaddition of alkyl azides with unstrained cycloalkenes via the transiently (reversibly) formed trans-cycloalkene. We assess this system via the rapid bioconjugation of azide-functionalized insulin. An attractive feature of this process is the cleavable nature of the linker, which makes a catch-and-release strategy possible. In broader terms, we show that conversion of photochemical energy to intramolecular ring strain is a powerful strategy that can facilitate complex chemical transformations, even in biomolecular systems. Probing, isolating, and/or manipulating biologically relevant macromolecules is central to the study of their function in living systems. However, the synthetic tools available for performing the chemistry necessary for such studies are often difficult to use or limited in utility. In the approach presented here, light is converted to molecular strain energy, which can in turn be used for performing rapid and highly selective chemistry on macromolecular systems. Because it involves chemically stable and chemoselective reactions, this research not only opens up new possibilities for biomolecular functionalization and manipulation but also promises to make such experiments accessible to a broader class of researchers. The central concept of strain-loadable alkenes is general and provides a firm foundation for light-activated chemistry in complex environments. Strain-loadable alkenes are cycloalkenes that, when irradiated in the presence of a visible-light-absorbing photocatalyst, undergo double-bond isomerization. Because of engineered geometrical constraints, this isomerization results in significant molecular strain. Weaver and colleagues exploit this strain to dramatically accelerate the cycloaddition with azides, which are otherwise unreactive, in mixed molecular environments.

NOVEL HISTONE METHYLTRANSFERASE INHIBITORS

-

, (2021/04/01)

The present invention relates to novel compounds of formula (I) as defined herein. The compounds are inhibitors of histone methyltransferases of the seven-beta-strand family, in particular of KMT9.

Method for synthesizing L- cystathionine hydrochloride (by machine translation)

-

Paragraph 0007; 0020; 0023-0024, (2020/07/24)

The invention relates to a synthetic method of L - cystathionine hydrochloride. The method mainly solves the technical problems of potential safety hazards and difficulty in purification in the existing synthetic method. To L - homoserine which can be lar

Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions

Patterson, Jaclyn R.,Terrell, Lamont R.,Donatelli, Carla A.,Holt, Dennis A.,Jolivette, Larry J.,Rivero, Ralph A.,Roethke, Theresa J.,Shu, Arthur,Stoy, Patrick,Ye, Guosen,Youngman, Mark,Lawhorn, Brian G.

, (2020/12/01)

Investigation of TRPV4 as a potential target for the treatment of pulmonary edema associated with heart failure generated a novel series of acyclic amine inhibitors displaying exceptional potency and PK properties. The series arose through a scaffold hopp

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 105183-60-6